Rankings
▼
Calendar
LIVN Q3 2024 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q3 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$318M
+11.2% YoY
Gross Profit
$225M
70.8% margin
Operating Income
$36M
11.2% margin
Net Income
$33M
10.4% margin
EPS (Diluted)
$0.60
QoQ Revenue Growth
-0.1%
Cash Flow
Operating Cash Flow
$51M
Free Cash Flow
$33M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$2.5B
Total Liabilities
$1.2B
Stockholders' Equity
$1.3B
Cash & Equivalents
$346M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$318M
$286M
+11.2%
Gross Profit
$225M
$202M
+11.6%
Operating Income
$36M
$4M
+699.0%
Net Income
$33M
-$7M
+550.3%
Revenue Segments
Cardiopulmonary Segment
$172M
55%
Neuromodulation Segment
$140M
45%
Geographic Segments
UNITED STATES
$180M
57%
Locations Excluding The United States And Europe
$85M
27%
Europe
$53M
17%
← FY 2024
All Quarters
Q4 2024 →